Substance / Medication

Sulconazole

Overview

Active Ingredient
sulconazole
RxNorm CUI
37319

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Comparison of the chiral resolution of econazole, miconazole, and sulconazole by HPLC using normal-phase amylose CSPs.
Aboul-Enein H Y, Ali I · Fresenius J Anal Chem · 2001
PMID: 11569882Observational
Microemulsion Based Gel of Sulconazole Nitrate for Topical Application.
Payyal Sumedha Prashanth, Rompicherla Narayana Charyulu, Sathyanarayana Sandeep Divate et al. · Turk J Pharm Sci · 2020
PMID: 32636702OtherFull text (PMC)
Sulconazole induces pyroptosis promoted by interferon-γ in monocyte/macrophage lineage cells.
Miyawaki Shiori, Sawamoto Atsushi, Okuyama Satoshi et al. · J Pharmacol Sci · 2024
PMID: 38395517Preclinical
Sulconazole-Loaded Solid Lipid Nanoparticles for Enhanced Antifungal Activity: In Vitro and In Vivo Approach.
Samee Ayesha, Usman Faisal, Wani Tanveer A et al. · Molecules · 2023
PMID: 38005230PreclinicalFull text (PMC)
Sulconazole inhibits PD-1 expression in immune cells and cancer cells malignant phenotype through NF-κB and calcium activity repression.
Pernot Simon, Tomé Mercedes, Galeano-Otero Isabel et al. · Front Immunol · 2023
PMID: 38250065PreclinicalFull text (PMC)
Development of sulconazole-loaded nanoemulsions for enhancement of transdermal permeation and antifungal activity.
Yang Qing, Liu Shanshan, Gu Yongwei et al. · Int J Nanomedicine · 2019
PMID: 31239665PreclinicalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Sulconazole (substance)
SNOMED CT
373448004
UMLS CUI
C0075503
RxNorm CUI
37319

Clinical Data

This intervention maps to 4 entities in the Ltrl knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.